Global Antithyroid Drug Market Growth (Status and Outlook) 2023-2029

Global Antithyroid Drug Market Growth (Status and Outlook) 2023-2029

Antithyroid drug is a drug for the treatment of hyperthyroidism. It mainly reduces the secretion of thyroid hormone by inhibiting thyroid synthesis.

LPI (LP Information)' newest research report, the “Antithyroid Drug Industry Forecast” looks at past sales and reviews total world Antithyroid Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Antithyroid Drug sales for 2023 through 2029. With Antithyroid Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antithyroid Drug industry.

This Insight Report provides a comprehensive analysis of the global Antithyroid Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antithyroid Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antithyroid Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antithyroid Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antithyroid Drug.

The global Antithyroid Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

The next decade will be full of promise in thyroid cancer diagnosis and treatment.With the increasing incidence of thyroid cancer, the scientific cognition of professionals and the public will also be further improved. There will be more investment in basic research, more targeted drugs will be developed and better drug efficacy will be achieved.Therefore, the anti-thyroid drug market still has a lot of room for growth in the future.

This report presents a comprehensive overview, market shares, and growth opportunities of Antithyroid Drug market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Thiourea
Iodine and Iodide
Radioiodine
β Receptor Blockers

Segmentation by application
Medical Treatment of Hyperthyroidism
Preparation for Thyroid Surgery
Treatment of Thyroid Crisis

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Shanghai Huanghai Pharmaceutical Co., Ltd
Merck KGaA
Lomapharm Rudolf Lohmann GmbH KG
Herbrand Pharmaceutical Chemistry Co., Ltd
Beijing Tongjida Pharmaceutical Co., Ltd
Shanghai Zhaohui Pharmaceutical Co., Ltd
Guangzhou Kanghe Pharmaceutical Co., Ltd
Hunan Hansen Pharmaceutical Co., Ltd
World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
Haimani Pharmaceutical Co., Ltd
Shanghai McLin Biochemical Technology Co., Ltd
Shanghai Yuanye Bio-Technology Co., Ltd
Amgen Inc
AbbVie Deutschland GmbH & Co.KG
Centrix Pharmaceutical Inc.
Pfizer Inc.
Actavis Totowa LLC
Caraco Pharmaceutical Laboratories
Boca Pharmacal Inc.
Heritage Pharmaceuticals Inc.
Par Pharmaceutical Inc
Sandoz Pharmaceuticals Inc.

Please note: The report will take approximately 2 business days to prepare and deliver. Show more